Evidence map›Paper›PMID 34127703›Full record

ArticleScientific reports2021

Cyclotide host-defense tailored for species and environments in violets from the Canary Islands.

Blazej Slazak, Klara Kaltenböck, Karin Steffen, Martyna Rogala, Priscila Rodríguez-Rodríguez, Anna Nilsson, Reza Shariatgorji, Per E Andrén, Ulf Göransson

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Production of Plant Proteins and Peptides with Pharmacological Potential.Advances in biochemical engineering/biotechnology · 2024
    Review
  7. Protein and peptide letters · 2024
    Article
  8. Article
  9. A Revised Phylogenetic Classification forPlants (Basel, Switzerland) · 2022
    Review
  10. Article
  11. Article
  12. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Blazej Slazak *W. Szafer Institute of Botany, Polish Academy of Science, 46 Lubicz St., 31-512, Kraków, Poland. b.slazak@botany.com.
Klara Kaltenböck *Department of Pharmaceutical Biosciences, Pharmacognosy, Uppsala University, Biomedical Centre (BMC) 574, 75123, Uppsala, Sweden.
Karin SteffenDepartment of Pharmaceutical Biosciences, Pharmacognosy, Uppsala University, Biomedical Centre (BMC) 574, 75123, Uppsala, Sweden.
Martyna RogalaDepartment of Plant Physiology and Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Kraków, Poland.
Priscila Rodríguez-RodríguezInstituto Universitario de Estudios Ambientales y Recursos Naturales (IUNAT), Universidad de Las Palmas de Gran Canaria, Campus Universitario de Tafira, 35017, Las Palmas de Gran Canaria, Canary Islands, Spain.
Anna NilssonDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, Biomedical Centre (BMC) 591, 75124, Uppsala, Sweden.
Reza ShariatgorjiDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, Biomedical Centre (BMC) 591, 75124, Uppsala, Sweden.
Per E AndrénDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, Biomedical Centre (BMC) 591, 75124, Uppsala, Sweden.
Ulf GöranssonDepartment of Pharmaceutical Biosciences, Pharmacognosy, Uppsala University, Biomedical Centre (BMC) 574, 75123, Uppsala, Sweden.
Uppsala University · SEScience for Life Laboratory · SEJagiellonian University · PLUniversidad de Las Palmas de Gran Canaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclotides are cyclic peptides produced by plants. Due to their insecticidal properties, they are thought to be involved in host defense. Violets produce complex mixtures of cyclotides, that are characteristic for each species and variable in different environments. Herein, we utilized mass spectrometry (LC-MS, MALDI-MS), transcriptomics and biological assays to investigate the diversity, differences in cyclotide expression based on species and different environment, and antimicrobial activity of cyclotides found in violets from the Canary Islands. A wide range of different habitats can be found on these islands, from subtropical forests to dry volcano peaks at high altitudes. The islands are inhabited by the endemic Viola palmensis, V. cheiranthifolia, V. anagae and the common V. odorata. The number of cyclotides produced by a given species varied in plants from different environments. The highest diversity was noted in V. anagae which resides in subtropical forest and the lowest in V. cheiranthifolia from the Teide volcano. Transcriptome sequencing and LC-MS were used to identify 23 cyclotide sequences from V. anagae. Cyclotide extracts exhibited antifungal activities with the lowest minimal inhibitory concentrations noted for V. anagae (15.62 μg/ml against Fusarium culmorum). The analysis of the relative abundance of 30 selected cyclotides revealed patterns characteristic to both species and populations, which can be the result of genetic variability or environmental conditions in different habitats. The current study exemplifies how plants tailor their host defense peptides for various habitats, and the usefulness of cyclotides as markers for chemosystematics.

Indexed as

Chromatography, LiquidCyclotidesFusariumGene Expression ProfilingGeographyHost-Pathogen InteractionsMicrobial Sensitivity TestsPlant ProteinsSpainSpecies SpecificityViolaCyclotidesPlant Proteins

Identifiers

PMID34127703
PMCPMC8203695
OpenAlexW3166352261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.